DiRaimondo, T. R., Klöck, C., & Khosla, C. (2012). Interferon-γ Activates Transglutaminase 2 via a Phosphatidylinositol-3-Kinase-Dependent Pathway: Implications for Celiac Sprue Therapy. The American Society for Pharmacology and Experimental Therapeutics.
Dyfyniad Arddull ChicagoDiRaimondo, Thomas R., Cornelius Klöck, and Chaitan Khosla. Interferon-γ Activates Transglutaminase 2 Via a Phosphatidylinositol-3-Kinase-Dependent Pathway: Implications for Celiac Sprue Therapy. The American Society for Pharmacology and Experimental Therapeutics, 2012.
Dyfyniad MLADiRaimondo, Thomas R., Cornelius Klöck, and Chaitan Khosla. Interferon-γ Activates Transglutaminase 2 Via a Phosphatidylinositol-3-Kinase-Dependent Pathway: Implications for Celiac Sprue Therapy. The American Society for Pharmacology and Experimental Therapeutics, 2012.